Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1

Vaccine

Volumn 31, Issue 46, 2013, Pages 5405-5412

  Schwarzer, Martin ^a   Srutkova, Dagmar ^a   Schabussova, Irma ^b   Hudcovic, Tomas ^a   Akgün, Johnnie ^b   Wiedermann, Ursula ^b   Kozakova, Hana ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergy; Bifidobacterium; Germ free mice; Probiotics; TLR2

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; POLLEN ANTIGEN; TOLL LIKE RECEPTOR 2;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; BIRCH; CELL STRAIN HEK293; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GERMFREE ANIMAL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SPLEEN CELL; TH1 CELL; TH2 CELL;

ALLERGY; BIFIDOBACTERIUM; GERM-FREE MICE; PROBIOTICS; TLR2;

ANIMALS; ANTIGENS, PLANT; BIFIDOBACTERIUM; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL TRACT; GERM-FREE LIFE; HEXOSAMINIDASES; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNOGLOBULIN E; MALE; MICE; MICE, INBRED BALB C;

EID: 84886099820     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.014     Document Type: Article

References (32)

1. Bieber T. Atopic dermatitis. N Eng J Med 2008, 358:1483-1494.
2. Martino D.J., Prescott S.L. Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 2010, 65:7-15.
3. Pfefferle P.I., Pinkenburg O., Renz H. Fetal epigenetic mechanisms and innate immunity in asthma. Curr Allergy Asthma Rep 2010, 10:434-443.
4. Okada H., Kuhn C., Feillet H., Bach J.F. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010, 160:1-9.
5. Candela M., Rampelli S., Turroni S., Severgnini M., Consolandi C., De Bellis G., et al. Unbalance of intestinal microbiota in atopic children. BMC Microbiol 2012, 12:95.
6. Bjorksten B., Sepp E., Julge K., Voor T., Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001, 108:516-520.
7. Kalliomaki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001, 107:129-134.
8. Penders J., Thijs C., van den Brandt P.A., Kummeling I., Snijders B., Stelma F., et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007, 56:661-667.
9. Kalliomaki M., Antoine J.M., Herz U., Rijkers G.T., Wells J.M., Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 2010, 140:21S-713S.
10. Toh Z.Q., Anzela A., Tang M.L., Licciardi P.V. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol 2012, 3:171.
11. Banchereau J., Pascual V., O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012, 13:925-931.
12. Hammad H., Lambrecht B.N. Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses. Allergy 2011, 66:579-587.
13. Konieczna P., Groeger D., Ziegler M., Frei R., Ferstl R., Shanahan F., et al. Bifidobacterium infantis 35624 administration induces Foxp3T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2012, 61:354-366.
14. Akdis C.A., Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011, 127:18-27. quiz 8-9.
15. Schabussova I., Hufnagl K., Tang M.L., Hoflehner E., Wagner A., Loupal G., et al. Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS ONE 2012, 7:e40271.
16. Feleszko W., Jaworska J., Rha R.D., Steinhausen S., Avagyan A., Jaudszus A., et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007, 37:498-505.
17. Tlaskalova-Hogenova H., Stepankova R., Kozakova H., Hudcovic T., Vannucci L., Tuckova L., et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011, 8:110-120.
18. Schwarzer M., Repa A., Daniel C., Schabussova I., Hrncir T., Pot B., et al. Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 2011, 66:368-375.
19. Repa A., Kozakova H., Hudcovic T., Stepankova R., Hrncir T., Tlaskalova-Hogenova H., et al. Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora. Immunol Lett 2008, 117:50-56.
20. Repa A., Grangette C., Daniel C., Hochreiter R., Hoffmann-Sommergruber K., Thalhamer J., et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003, 22:87-95.
21. Golias J., Schwarzer M., Wallner M., Kverka M., Kozakova H., Srutkova D., et al. Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS ONE 2012, 7:e37156.
22. Tang M.L., Lahtinen S.J., Boyle R.J. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 2010, 22:626-634.
23. Renz H., Conrad M., Brand S., Teich R., Garn H., Pfefferle P.I. Allergic diseases, gene-environment interactions. Allergy 2011, 66(Suppl. 95):10-12.
24. Schabussova I., Hufnagl K., Wild C., Nutten S., Zuercher A.W., Mercenier A., et al. Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization. Vaccine 2011, 29:1981-1990.
25. Zhang L.L., Chen X., Zheng P.Y., Luo Y., Lu G.F., Liu Z.Q., et al. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 2010, 25:928-934.
26. Lyons A., O'Mahony D., O'Brien F., MacSharry J., Sheil B., Ceddia M., et al. Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy 2010, 40:811-819.
27. Jeon S.G., Kayama H., Ueda Y., Takahashi T., Asahara T., Tsuji H., et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 2012, 8:e1002714.
28. Pulendran B., Tang H., Manicassamy S. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol 2010, 11:647-655.
29. Taylor R.C., Richmond P., Upham J.W. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 2006, 117:1148-1154.
30. Chen Q., Davidson T.S., Huter E.N., Shevach E.M. Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival. J Immunol 2009, 183:4458-4466.
31. Wu M.-H., Pan T.-M., Wu Y.-J., Chang S.-J., Chang M.-S., Hu C.-Y. Exopolysaccharide activities from probiotic bifidobacterium: immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties. Int J Food Microbiol 2010, 144:104-110.
32. Takeda K., Akira S. TLR signaling pathways. Semin Immunol 2004, 16:3-9.